



2010, Vol. 17, No. 5, pp. 503–508
Copyright © 2010 Via Medica
ISSN 1897–5593
Address for correspondence:  Barbara Małecka, MD, PhD, Department of Electrocardiology, Institute of Cardiology,
Jagiellonian University Collegium Medicum, John Paul II Hospital in Krakow, Prądnicka 80, 31–202 Kraków, Poland,
tel./fax: +48 12 633 23 99, e-mail: barbara_malecka@go2.pl
Received: 9.07.2009 Accepted: 18.10.2009
Resynchronization therapy transvenous approach
in dextrocardia and congenitally corrected
transposition of great arteries
Barbara Małecka1, Jacek Bednarek1, Lidia Tomkiewicz-Pająk2,
Piotr Klimeczek3, Andrzej Ząbek1, Mieczysław Pasowicz3, Jacek Lelakowski1
1Department of Electrocardiology, Institute of Cardiology, Jagiellonian University
Collegium Medicum, John Paul II Hospital in Krakow, Krakow, Poland
2Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University
Collegium Medicum, John Paul II Hospital in Krakow, Krakow, Poland
3Center for Diagnosis, Prevention and Telemedicine with one-day Diagnostic Unit,
John Paul II Hospital in Krakow, Krakow, Poland
Abstract
Cardiac resynchronization therapy (CRT) is an acknowledged treatment for advanced heart
failure in acquired dilated cardiomyopathy, resistant to pharmacotherapy. Although there are
no therapeutic standards regarding heart failure originating from congenital heart defects
with systemic right ventricle, a number of CRT implantations by transvenous approach in
congenitally corrected transposition of the great arteries (CCTGA) have been reported since
2001, even though none of them expressly referred to a case concomitant with dextrocardia and
situs inversus anomaly.
We present a 57 year-old patient with dextrocardia and CCTGA, who underwent surgical
closure of interatrial and interventricular septal defects at the age of 19, and in whom a VVI
pacemaker was subsequently implanted at age 36. A three-lead CRT system was implanted by
transvenous approach. Imaging techniques, including multi-slice computed tomogra-
phy, targeted to pacing system and unusual anatomical relationships were applied. Within
a 20-month follow-up, a significant improvement of functional NYHA class, systemic right
ventricle ejection fraction and exercise capability were observed.
Entirely transvenous CRT system implantation is feasible in patients with dextrocardia and
CCTGA, and has substantial potential for long-term benefits. (Cardiol J 2010; 17, 5: 503–508)
Key words: cardiac resynchronization therapy, CCTGA, transvenous approach,
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Introduction
Biventricular pacing in dilated cardiomyopa-
thy with severe left ventricular (LV) systolic dys-
function, electromechanical delay and chronic
heart failure (HF), despite optimal pharmacothera-
py, has been demonstrated in randomized clinical
studies to improve overall quality of life, functional
class, exercise capability and echocardiographic pa-
rameters [1, 2]. Cardiac resynchronization therapy
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(CRT) has recently also been proved helpful in
reducing all-cause mortality or unplanned hospi-
talization for major cardiovascular events [3, 4].
Despite no established clinical standards for
CRT in congenital heart disorders, such interven-
tions are still being embraced in advanced HF cas-
es in adults and children alike [5–8]. It must be em-
phasized that CRT is widely acknowledged to be the
most challenging among heart pacing procedures,
especially in terms of the placement of the lead for
LV stimulation, using the transvenous approach
through the coronary sinus.
An additional difficulty lies in the variable ana-
tomy of the coronary sinus itself, this being espe-
cially true for any congenital disorders. Dextrocar-
dia complicates the procedure even more, because
the shapes of commercially available LV pacing
devices are suitable for left-hand sided coronary
sinus in the left-subclavian vein approach [9].
In congenital corrected transposition of great
arteries (CCTGA), the anatomical LV connects the
right atrium to a posteriorly placed pulmonary ar-
tery. The anatomical right ventricle (RV) connects
the left atrium to the anteriorly placed aorta. Ow-
ing to the abnormal relationship between the atria
and the ventricles, and the ventricles with the aor-
ta and the pulmonary artery respectively, we are
actually looking at a functional correction of the cir-
culation. Consequently, blood flows in the normal
direction, although passing through the “wrong”
ventricular chamber [10].
The atrio-ventricular (AV) node and His bun-
dle have an unusual position and course, thus mak-
ing the conduction system inverted, whereas His
bundle is elongated. Many patients also reveal dual
AV nodes. The second anomalous AV node and
bundle are usually anterior, whereas the penetrat-
ing bundle is vulnerable to fibrosis with advancing
age. This makes the conduction system tenuous,
with a progressive incidence of complete AV block
occurring at ª2% annually [10, 11]. It should be
noted at this point that ventricular septal defect
(VSD) surgery, as in this particular case, may also
precipitate heart block. It makes it necessary to
perform long-term pacing with negative hemody-
namic effects on the systemic RV which constitutes
first risk factor for gradual development of HF.
The anatomy of coronary arteries is concordant
with the morphology of ventricles. Systemic RV is
perfused only by a single right coronary artery,
which, through exposure to systemic pressure, may
cause substantial impairment to myocardial perfu-
sion [10, 12, 13]. This constitutes a second risk fac-
tor for HF in those patients. Most of them survive
until advanced age and become good candidates for
CRT therapy [5, 6].
The coronary sinus is ontogenically a part of
the left atrium, being in fact located at the side of
the left atrium, both in terms of morphological and
circulatory constraints. Hence, the coronary sinus
is adjacent to the systemic RV in CCTGA patients.
Therefore, in CCTGA, the coronary sinus and its
tributaries drain blood predominantly from the sys-
temic RV, which makes them perfectly suitable for
the placement of a lead for systemic RV stimula-
tion [5–8].
To the best of our knowledge, no cases of fully
transvenous CRT system introduction via the left
subclavian vein approach for the treatment of HF
in patients with CCTGA associated with dextrocar-
dia have been reported to date.
Case report
A 57 year-old man with CCTGA and situs vis-
cerum inversus with dextrocardia had experienced
several hospital admissions due to NYHA class III
HF symptoms, despite optimal pharmacotherapy
(carvedilol, spironolacton and cilazapril).
At the age of 19, he underwent surgery of the
interatrial and interventricular septal defect (ASD
and VSD) closure, complicated by the right bundle
branch block.
Seventeen years later, a single ventricular
chamber pacing device (VVI) with epicardial ven-
tricular lead, introduced by surgical thoracotomy
method, was implanted, due to the development of
complete AV block. The lead was located in the pul-
monic LV apex, whereas the pacemaker was in the
epigastric region.
The patient remained asymptomatic until the
age of 47, when he started experiencing dyspnoea,
fatigue and paroxysmal atrial tachycardia, resulting
in hospitalization twice a year on average.
At the last admission, his blood pressure was
90/60–100/70 mm Hg, whereas the pacemaker func-
tion remained normal. Ventricular pacing 70/min
with the rate response rise up to 110/min, and QRS
of 170 ms width were registered (Fig. 1B).
Echocardiography revealed severe systolic
ventricular dysfunction, bi-atrial and bi-ventricular
dilatation, with a systemic RV ejection fraction of
only 24%, as assessed by single-plane Simpson rule
(Table 1). Moderate anatomical mitral and tricuspid
valve regurgitation, pulmonary valvular stenosis
with a gradient of 40–44 mm Hg on Doppler
echocardiography, and the pulmonary trunk aneu-
rysm were also found. An interventricular mecha-
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nical dyssynchrony of 84 ms was calculated and the
post-systolic contraction of the systemic RV free
wall was also observed (Fig. 2A, B). The 6-min
walking-test (6MWT) and spirometry revealed
significant impairment of physical effort capacity
(Table 1).
Coronary angiography revealed atypical coro-
nary aortic inlets without coronary artery stenosis,
i.e. the right artery and left anterior descendant
artery from anterior Valsalva sinus, circumflex ar-
tery from posterior Valsalva sinus.
CRT system implantation
— procedure description
Coronary sinus lumen visualization was ob-
tained using the Medtronic Attain set (Fig. 1A).
A Medtronic 4193 stylet-driven lead was ad-
vanced into the anterior branch of the coronary si-
nus in order to pace the systemic RV. All previous
attempts aimed at placing the lead in the posterior
and postero-lateral branches of the coronary sinus
had failed due to mechanical instability and high
pacing thresholds. The Medtronic 5076 screw-in
lead was placed in pulmonic LV outflow track under-
neath the pulmonary valve. Subsequently, the
Medtronic 5076 screw-in lead was located in the right
atrium, close to the coronary sinus outflow. These
three leads were attached to a Medtronic pacemaker
Insync III 8042 (Fig. 1D). The pacing and measure-
ment of bioelectrical parameters at all the leads ap-
peared satisfactory. Immediately after the introduc-
tion of CRT pacing, the duration of QRS has decreased
from the initial 170 ms down to 140 ms (Fig. 1C).
Aiming to obtain the shortest possible inter-
ventricular dyssynchrony and optimal mitral flow
time (as measured by ECHO), the atrio-ventricu-
lar and inter-ventricular delays were programmed
as follows: AV delay sensed at 110 ms, AV delay
Figure 1. A. Angiography demonstrating coronary sinus with cardiac veins. The retouch of coronary sinus distal part
— anterior cardiac vein (R); B, C. Electrocardiography. The leads I, II, III. The lead configuration adopted for
dextrocardia. Paper speed 25 mm/s; B. Epicardial VVI pacing from the pulmonic left ventricular apex; C. DDD BiV
(CRT), sequential atrio-biventricular pacing. Details regarding A-V and V-V delays in the text; D. Chest X-ray —
postero-anterior projection. Three transvenous pacemaker leads are visible in the right atrium (1), the cardiac vein (2)
and in the pulmonic left ventricle (3). The old, detached epicardial lead is also visible (4).
Table 1. 20-month follow-up.
Before                     After implantation
implantation
1 month 6 months 12 months 20 months
NYHA III III III II II
Systemic RVEF (%) 24 30 30 30 40
6-min walking test [m] 392 443 484 498 438*
Spiroergometric test (VO2max) [mL/kg/min] 10.9 – – 17.1 –
*Test carried out during the discopathy-originated pain symptoms; RVEF — right ventricular ejection fraction
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paced at 130 ms, and VV delay at 16 ms, with prior
systemic RV stimulation. The interventricular con-
duction delay of 36 ms was obtained, indicating the
interventricular dyssynchrony to have decreased by
more than 50% in comparison to the initial value
(Fig. 2C, D). The previously installed pacemaker
was removed, although its 19 year-old epicardial
lead was left in place.
Subsequently, the patient was discharged from
hospital (presenting symptoms of NYHA class III
HF) and put on cilazapril, carvedilol, spironolacton
and aspirin.
20-month follow up
The follow-up was carried out one, six, 12 and
20 months following the procedure. The results of clini-
cal observation, as assessed by NYHA class, 6MWT,
spiroergometric test and systemic RV ejection frac-
tion ECHO measurement, can be seen in Table 1.
Before CRT
After CRT
IVCD = 84 mssRV PEP = 192 ms pLV PEP = 108 ms
IVCD = 36 mssRV PEP = 144 ms pLV PEP = 108 ms
Figure 2. Echocardiography; A, C. Right-sided parasternal modified projection; B, D. Five chamber apical projection.
Inter-ventricular dyssynchrony features are shown. The interventricular conduction delay (IVCD) measurement in the
text; sRV — systemic right ventricle; pLV — pulmonic left ventricle; CRT — cardiac resynchronization therapy.
Within one month of the procedure, atrial flut-
ter was observed. Following initial pharmacother-
apy with digoxin and an anticoagulation agent, it was
converted (using rapid atrial over-drive pacing) into
atrial tachycardia 170/min with the 2:1 ventricular
pacing. This arrhythmia, still observed during the
follow-up visit after  six months, spontaneously dis-
appeared after another six months and the sinus
rhythm was re-established. Holter ambulatory re-
cording obtained 20 months after the implantation
revealed paroxysmal atrial flutter, despite the con-
tinued antiarrhythmic treatment.
MSCT visualisation
Prior to the CRT procedure, coronary angio-
graphy was performed. Multi-slice computed tomo-
graphy (MSCT) was performed during the follow-up
period in order to visualize the leads, arteries and
venous inflow system (Fig. 3). Aorta arose from the
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morphological RV and pulmonary trunk from the
morphological LV.
Abnormal coronary artery outflows were reco-
gnized, i.e. the right artery and anterior descendent
coronary artery originating from the anterior Val-
sava sinus, and circumflex artery originating from
the posterior sinus. The right coronary artery sup-
plied blood to the myocardium of systemic RV
through a number of branches. The left anterior
descendent artery (originating from the anterior
Valsalva sinus in close proximity to the right coro-
nary artery, running its course through the interven-
tricular groove) supplies blood into the interventric-
ular septum. The circumflex artery, turned behind
the pulmonary trunk and running along the groove
between the right atrium and pulmonic LV, supplied
blood to the myocardium of this ventricle (Fig. 3).
The cardiac veins are also shown (Fig. 3).
Coronary sinus and posterior cardiac vein circu-
lated the blood back to the right atrium. Two veins
(i.e. posterior and postero-lateral) had inlets to the
coronary sinus, whereas the remnant structure
resembled the anterior vein. In this vessel, the tip
of systemic RV lead was found to approach the la-
teral systemic RV wall and then turn upward to the
RV outflow track.
Figure 3. A, B. Multi-slice computed tomography — 3D projection. Coronary arteries and cardiac veins are shown;
A. View of the upper part of the heart. Cut-off at the level of great vessels; 1 — coronary sinus with the lead; 2 — right
coronary artery; 3 — left anterior descendent coronary artery; 4 — left circumflex coronary artery; Ao — aorta;
PT — pulmonary trunk; PV — pulmonary veins; sVC — superior vena cava; B. View of the right lateral wall of the
heart; 1 — coronary sinus with the lead; 2 — posterior and lateral branches of coronary sinus; 3 — posterior cardiac
vein; 4 — right coronary artery; sRV — systemic right ventricle; LA — left atrium.
Discussion
Patients with CCTGA are significantly suscep-
tible to systemic ventricle insufficiency. Key pre-
disposing factors are the chamber of RV-like struc-
ture and blood perfusion being exposed to high
blood pressure and concomitant AV conduction dis-
turbances in the form of bundle branch blocks, up
to the second and third degree AV block resulting
in ventricular bradycardia. The pattern of bundle
branch blocks originating from pulmonic LV pacing
may generate typical pacing-induced interventri-
cular dyssynchrony, with subsequent intensive dys-
synchrony of mechanical contraction [5, 10–13].
In the study by Diller at al. [5], the demand for
CRT in patients with systemic ventricle was esti-
mated as around 4%, in due consideration of stan-
dard indications for CRT implantation.
Nowadays, the vast majority of CRT devices
are implanted through the transvenous approach,
widely acknowledged to be a much safer method
than thoracotomy, although only a few reports deal
with the actual implantation of transvenous pacing
leads in CCTGA patients [6–8].
In the presently discussed CCTGA case, the
additional impediment in advancing transvenous
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leads consisted in situs inversus with dextrocardia
in the right-handed patient, in whom the left-sided
approach was preferable due to his high physical
activity and possible damage to the leads in the
‘crush syndrome’ during active use of his right hand.
Only a single case of CRT implantation in
a patient with dextrocardia was actually found in the
literature, although this dealt with the right-sided
transvenous approach only [9].
We effectively managed to create a three-lead
stimulation system through the successful implanta-
tion of the first lead onto the antero-lateral wall un-
derneath the aortic valve ring in conjunction with the
placement of another one in the pulmonic ventricle
outflow track on the anterior wall. It was not optimal
in terms of theoretic rules of CRT implantation. Op-
timal implantation site in coronary sinus branch was
attempted, but finally abandoned due to mechanical
instability and high pacing thresholds. The third lead
in the right atrium, in the proximity of the inflow to
the coronary sinus, was also implanted. The AV and
VV delays were programmed in compliance with the
actual echocardiographic findings. Mechanical con-
traction dyssynchrony diminished by over 50%.
In the long-term, 20-month follow-up, improve-
ment of functional NYHA class, systemic RV ejec-
tion fraction, and capacity of physical effort were
noted, with no significant decrease in either of the
systemic ventricle diameters.
Application of MSCT after the surgical interven-
tion facilitated the imaging of the venous vascular bed,
therefore affording a much deeper insight into the
anatomical complexities of this rather rare congeni-
tal heart disorder. Coronary angiography was per-
formed prior to the CRT procedure to ease visualisa-
tion of potential significant stenosis of coronary arte-
ries caused by atherosclerosis in a 57 year-old patient.
Conclusions
Resynchronization therapy by a transvenous
approach in patients with complex heart anatomy
in CCTGA and situs inversus with dextrocardia is
a feasible, low-risk surgical procedure, despite
there being no established clinical standards and
scarcity of pertinent experience.
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